Intratumor heterogeneity seen in renal carcinomas

March 8, 2012
Intratumor heterogeneity seen in renal carcinomas

(HealthDay) -- Extensive intratumor heterogeneity, seen in samples obtained from renal carcinomas, may lead to underestimation of the tumor genomics based on single tumor-biopsy samples, according to a study published in the March 8 issue of the New England Journal of Medicine.

To investigate intratumor heterogeneity, Marco Gerlinger, M.D., from the Cancer Research U.K. London Research Institute, and colleagues performed exome sequencing, chromosome aberration analysis, and ploidy profiling on multiple spatially separated samples from primary renal carcinomas and associated metastatic sites. The consequences of this heterogeneity were characterized using immunohistochemical analysis, mutation functional analysis, and expression profiling.

The researchers found that phylogenetic reconstruction showed branched evolutionary tumor growth; and across every tumor region, 63 to 69 percent of were not detectable. Intratumor heterogeneity was seen for a mutation within an autoinhibitory domain of the mammalian target of rapamycin kinase, and mutational heterogeneity was observed for multiple tumor-suppressor genes converging on loss of function. In different regions of the same tumor, gene-expression signatures of good and were seen. Extensive intratumor heterogeneity was seen on allelic composition and ploidy profiling analysis.

"Intratumor heterogeneity may explain the difficulties encountered in the validation of oncology biomarkers owing to sampling bias, contribute to Darwinian selection of preexisting drug-resistant clones, and predict therapeutic resistance," the authors write. "Reconstructing tumor clonal architectures and the identification of common mutations located in the trunk of the phylogenetic tree may contribute to more robust biomarkers and therapeutic approaches."

The study was partially funded by Novartis; several authors disclosed with pharmaceutical companies, including Novartis.

Explore further: New statistical method could improve search for genes involved in common diseases

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

New statistical method could improve search for genes involved in common diseases

May 17, 2011
Recent breakthroughs in the analysis of genetic variation in large populations have led to the discovery of hundreds of genes involved in dozens of common diseases. Many of these discoveries were enabled by performing "meta-analysis," ...

Single-cell sequencing leads to a new era of cancer research

March 2, 2012
BGI, the world's largest genomics organization, developed single-cell genome sequencing technology and published two research papers for cancer single-cell sequencing in the research journal Cell. In the papers, which were ...

Epigenetic study reveals new insights into breast cancer

May 5, 2011
The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, Belgian researchers have reported.

Molecular profiling reveals differences between primary and recurrent ovarian cancers

February 10, 2012
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling ...

Recommended for you

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.